Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Chiarelli

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
JAMA Surgery|December 28, 2022
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After SurgerySimone Famularo, Matteo Donadon, Federica Cipriani, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 16, 2025
Minimally invasive versus open liver resection for nonmetastatic hepatocellular carcinoma staged BCLC - B and - C: an Italian multicentric analysisGianluca Cassese, Mariano C Giglio, Alessandro Vitale, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 25, 2023
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenarioSimone Famularo, Umberto Cillo, Andrea Lauterio, et al.
Cancers|December 29, 2020
Performance of Comprehensive Complication Index and Clavien-Dindo Complication Scoring System in Liver Surgery for Hepatocellular CarcinomaAlessandro Giani, Federica Cipriani, Simone Famularo, et al.
JAMA Surgery|May 21, 2024
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular CarcinomaAlessandro Vitale, Pierluigi Romano, Umberto Cillo, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
JAMA Surgery|December 28, 2022
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After SurgerySimone Famularo, Matteo Donadon, Federica Cipriani, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 16, 2025
Minimally invasive versus open liver resection for nonmetastatic hepatocellular carcinoma staged BCLC - B and - C: an Italian multicentric analysisGianluca Cassese, Mariano C Giglio, Alessandro Vitale, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 25, 2023
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenarioSimone Famularo, Umberto Cillo, Andrea Lauterio, et al.
Cancers|December 29, 2020
Performance of Comprehensive Complication Index and Clavien-Dindo Complication Scoring System in Liver Surgery for Hepatocellular CarcinomaAlessandro Giani, Federica Cipriani, Simone Famularo, et al.
JAMA Surgery|May 21, 2024
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular CarcinomaAlessandro Vitale, Pierluigi Romano, Umberto Cillo, et al.
Pageof 6